PurchasesCluster BuysBig Buys $500k+SalesMarket Trades More views → Custom filter →

Ticker page

BCAX Insider Trading Activity

Track Bicara Therapeutics Inc. (BCAX) insider transactions, SEC Form 4 filings, insider buys, insider sales, filing dates, trade values, and source links. Recent summary: 10 trades, 0 buys, and 0 sales. Learn more

Feed status Last SEC check:Loading Last Filing: Loading
View BCAX
Access Free feed
Quick read What does this view show?

What this shows

Market trades first

This view focuses on purchases and sales with reported trade value. Lower-signal rows are moved out of the first screen, not hidden.

How to read a row →

Why it matters

Use it as the default scan

Start here when you want the newest activity that most retail investors expect from an insider trading feed.

How to read it

Open the full ledger when needed

Use All Form 4 Filings when you want grants, exercises, gifts, conversions, and every normalized row.

Transaction codes explained →

Filings

BCAX Form 4 filing history

Recent insider trading rows for this issuer. The SEC filing is the source record.

Status Loading

Loading public insider data...

Latest visible filing loading.

Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?

TickerType & RoleValue

Latest news

BCAX headlines

Plain-English summary

BCAX insider activity summary

Bicara Therapeutics Inc. (BCAX) insider activity over the recent reporting window shows no qualifying Form 4 activity in the recent window. Market data shows a current price of $22.92 and a market capitalization of $1.43B. Blue Collar Picks normalizes public SEC Form 4 filings into a research-friendly view organized by ticker, insider role, transaction type, filing date, and reported value. BCAX pages are designed as a research starting point, not investment advice. Verify the original SEC filing, read the transaction code, compare the trade against the insider's role and history, and consider whether the activity is an open-market purchase, a sale, a grant, an option exercise, or another lower-signal filing type before drawing conclusions.

Company snapshot

Bicara Therapeutics Inc. at a glance

Market Cap$1.43B
SectorHealthcare
IndustryBiotechnology
P/E (TTM)—
Forward P/E-6.0
Beta—
Dividend YieldNone
Shares Out65,703,866

Context

Earnings & analyst view

Earnings

Aug 10, 2026

Analyst View

$31.46 +45.05% upside

Target range $16.00–$46.00.

Ownership context

Top institutional holders

HolderShares% HeldValueReported
RA Capital Management, L.P.7,255,9930.11%$157.4MMar 31, 2026
T. Rowe Price Investment Management, Inc.6,605,7800.10%$143.3MMar 31, 2026
Siren, L.L.C.5,802,9700.09%$125.9MMar 31, 2026
Vestal Point Capital, LP5,425,0000.08%$117.7MMar 31, 2026
Deep Track Capital, Lp4,062,5000.06%$88.1MMar 31, 2026

Primary source

Verify with the original SEC filings

Blue Collar Picks normalizes public Form 4 records but the SEC filing is the source of record. Use the original filing before making any investment decision.

Open BCAX Form 4 filings on SEC EDGAR → See insider trading stocks ranked by activity → Read the Blue Collar Picks methodology → Read the investment disclaimer →

Weekly recap

Get the easier version in your inbox.

Start with the free weekly recap. Upgrade later if you want the paid daily brief.

Free weekly recap. No login required. Unsubscribe any time.

Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →